ResearcherUniversity of PennsylvaniaActive in the last 2 years

Margo Orlen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9834-6282; OpenAlex author ID A5059797626. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2024: 2 papers · 2025: 2 papers

Papers 4

Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. Co-author DOI 10.1158/1078-0432.ccr-24-4049 ↗
T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-24-1475 ↗
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-07379-z ↗
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08084-7 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Samantha B. Kemp · 2 shared papers, 2025 · strength 0.44
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Ben Z. Stanger · 2 shared papers, 2025 · strength 0.44
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Rong Zhou · 1 shared paper, 2025 · strength 0.23
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
Mark Alan Rosen · 1 shared paper, 2025 · strength 0.23
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
Stephen Pickup · 1 shared paper, 2025 · strength 0.23
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
Mamta Gupta · 1 shared paper, 2025 · strength 0.23
- Paper Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy. DOI 10.1158/1078-0432.ccr-24-4049 ↗
Robert H. Vonderheide · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Jayne C. McDevitt · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗
Mallika Singh · 1 shared paper, 2025 · strength 0.21
- Paper T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Mo… DOI 10.1158/2159-8290.cd-24-1475 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.